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Gold nanoparticles were grown on Sargassum muticum water extract (S-GNPs) using the green biosynthetic approach. The
nanoparticles were characterized using UV-visible spectroscopy, zeta potential, and transmission electron microscopy (TEM).The
resulting S-GNPs were spherical and crystalline with a size of <10 nm.The in vitro anticancer activity was demonstrated in human
leukemia cell lines. The cancer cells were treated with different concentrations of S-GNPs, and calorimetric (MTT) assay used
for the cytotoxicity test, which resulted in an IC
50
value of 4.22 ± 1.12, 5.71 ± 1.4, 6.55 ± 0.9, and 7.29 ± 1.7 𝜇g/mL for each of the
K562, HL-60, Jurkat, and CEM-ss cells, respectively. Thus, the K562 was selected for the next experiments. Furthermore, apoptosis
induction was confirmed by Hoechst 33342, annexin V staining, and caspase-3/-9 activity tests. The cell cycle analysis exhibited
a significant increase in the accumulation of S-GNPs treated cells at the sub-G1 phase, demonstrating the induction of apoptosis
by S-GNPs. The nature of the inhibition of cancer cell growth by S-GNPs could open the way for further research in the design of
green synthesis therapeutic agents, particularly in nanomedicine, for the treatment of cancer.
1. Introduction
Cancer, after heart disease and stroke, is the third leading
cause of death in developing countries. According to WHO,
cancers now account for approximately 13.3% of deaths and
are expected to rise by at least 50% worldwide over the next
20 years [1]. Gold nanoparticles (GNPs) have great potential
in the detection, diagnosis, and treatment of cancer [2].
For the preferred synthesis shape and size of GNPs there
is a challenging and important mission with improvements
of simple and flexible eco-friendly preparation methods.
Typically, using organic solvents and chemical reducing
agents for the synthesis of GNPs have raised environmen-
tal concerns due to the consequences of processing with
toxic compounds [3]. The use of nontoxic and eco-friendly
materials via green synthesis of metallic nanoparticles is
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being investigated to eliminate all possible biological risks
in biomedical and pharmaceutical applications [3]. Many
researchers are concentrating on bioactive natural products
from plants or other sources, such as bacteria, fungi, and
yeast, for the synthesis of metal nanoparticles [4–7]. Seaweed
is a functional food andmedicinal herb, the use ofwhich dates
back at least 5,000 years in ancient China [8].
Marine algae, in a wide variety of different species with
differentmedicinal behaviors, can be divided into two groups,
namely, microalgae and macroalgae. Marine macroalgae or
seaweeds are classified according to their pigmentation into
green (chlorophytes), red (rhodophytes), and brown (phaeo-
phytes) [9]. Seaweeds are rich sources of lipids, minerals, and
certain vitamins, and also several bioactive substances like
polysaccharides, proteins, and polyphenols, with potential
medicinal uses against cancer [10], oxidative stress [11, 12],
inflammation [13], allergy [14], diabetes [15], thrombosis [16],
obesity [17], lipidaemia [18], hypertension [19], and other
degenerative diseases.
The history, chemistry, biomedical effects, and medical
uses of seaweed species have been well documented and
reviewed elsewhere [20–24]. Gold salts content within sea-
weed antioxidant could be reduced to obtain nanoparticles
with specific properties offering potential applications in the
biomedical field. In a previous study, we synthesized and
characterized gold NPs using brown seaweed (Sargassum
muticum) extract via the green method [25]. The genus
Sargassum, a kind of brown algae comprising 150 species, is a
tropical and subtropical brown seaweed in subtidal and inter-
tidal areas [26]. The chemical and nutritional composition
of seaweeds varies with individual species [27], habitats [28],
and maturity and depends on the geographical origin or area
of cultivation [29], seasonal [30], environmental [29], and
physiological variations and water temperature [30, 31]. The
aim of this study was to investigate the cytotoxic effects of
gold NPs prepared by green biosynthesis on various human
cancer cell lines using a number of experimental methods.
2. Materials and Methods
2.1. Raw Material. Specimens of the Sargassum muticum
seaweed from the coastal areas of Persian Gulf waters were
collected, washed, and stored at −20∘C.
2.2. Chemicals. Hydrogen tetrachloroaurate (III) (HAuCl
4
⋅
3H
2
O, 99.98%), used as a good precursor, was obtained from
Sigma-Aldrich (St. Louis, MO, USA). All reagents in this
study were of analytical grade.
2.3. Synthesis of S-GNPs. Stabilized and biocompatible S-
GNPs were prepared by suspending 1.0 g of seaweed in
100mL of Milli-Q water. A volume of 50mL from 0.1M
HAuCl
4
solution was added to 50mL of the aqueous extract
of S. muticum under continuous stirring at 45∘C.The solution
changed color (light yellow to pink to cherry red) within
one hour indicating the formation of S-GNPs. For complete
reaction the obtained solution was left under stirring for
a further one hour. The S-GNPs formed were separated
from the residual seaweed by collecting the pellets after
centrifugation at 6000 rpm/10minutes.Thepellets were again
suspended in double distilled water and the pH adjusted by
adding 0.1mL of phosphate buffer to the whole volume to
physiological pH.
2.4. UV-Vis Absorption Spectroscopy. UV-Visible spectrawere
recorded using a Lambda 25-Perkin Elmer (Waltham, MA,
USA). The absorbance spectra were scanned in the range of
200–800 nm with a 1 nm interval at room temperature.
2.5. Zeta Potential (ZP) Measurement. The laser Doppler
electrophoresis technique was applied tomeasure the particle
electrostatic charge, in which 100𝜇L of the particle solution
was diluted with 1.5mL of water and placed into a cuvette
of the Zetasizer-nanoinstrument (Malvern, UK); the results
are expressed as zeta potential (ZP). The measurements were
performed in triplicate at a pH of 7.26 ± 0.13 to mimic
physiological pH.
2.6. Transmission Electron Microscopy (TEM). The TEM
micrographs were obtained using an H-7100 electron micro-
scope (Hitachi, Tokyo, Japan) instrument operated at an
accelerating voltage of 120KV. TEM samples were prepared
by dispersing small quantities of the dried sample in distillate
water and depositing a few drops of the resulting suspension
on a copper grid.
2.7. Cell Culture Condition. The human leukemia cell lines
K562 (chronic myelocytic leukaemia), Jurkat (acute lympho-
blastic leukaemia), CEM-ss (acute lymphocytic leukaemia),
and HL-60 (acute promyelocytic leukemia) were purchased
from the American Type Culture Collection (ATCC) (Mary-
land, USA). All cell lines except HL-60 were maintained in
RPMI-1640 (ATCC, USA) medium, supplemented with L-
glutamine (2Mm), 10% fetal bovine serum (FBS) (ATCC,
USA) and 100 units/mL penicillin, and 100 𝜇g/mL strepto-
mycin (SigmaAldrich, USA). However, the basal medium for
the HL-60 cell line was ATCC-formulated Iscove’s Modified
Dulbecco’sMedium (IMDM) supplemented with fetal bovine
serum to a final concentration of 20% and 100 units/mL peni-
cillin and 100 𝜇g/mL streptomycin (Sigma Aldrich, USA).
According to the ATCC protocol, all the cells were cultured
and grown in 75 cm2 culture flasks (TPP, Switzerland) at 37∘C
in an incubator with a humidified atmosphere of 95% air
and 5% CO
2
. The cultures were frequently examined under
an inverted microscope (Micros, Austria) for confluency and
viability.
2.8. Cytotoxicity Assay of S-GNPs toward Leukemia Cell Lines.
The cytotoxicity effects of S-GNPs at concentrations of 1 to
100 𝜇g/mL of cancer cells were quantified using the MTT
kit (Sigma Aldrich, USA) according to the instructions of
the manufacturing company. Briefly, the cells were allowed
to grow in a 75 cm2 cell culture flask until 90% confluent.
Then, the cells were plated at an initial cell count of 1 ×
103 cells per well, treated with various concentrations of S-
GNPs, and incubated for 72 hours at 37∘C in a 5% CO
2
.
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The MTT solution (Microculture Tetrazolium) (Sigma
Aldrich, USA) (25 𝜇L) was added to each well, covered
with aluminum foil, and incubated for an additional four
hours in the dark to allow the metabolically active viable
cells to convert the water-soluble yellow MTT solution into
water insoluble purple formazan crystals. The optical density
(OD) was measured at 570 nm using an ELISA plate reader
(Universal Microplate reader) (Biotech Inc., USA). The IC
50
value (concentration at which 50% of the cells are killed) was
determined from the dose-response curve.TheDMSO (0.1%)
was used as negative control. The assay was performed in
triplicate.
2.9. Cytotoxicity of S-GNPs toward Human Blood Mononu-
clear Cells. BD vacutainer (CPT ) was used for the separation
of primary lymphocytic cells from whole human blood.
About 8.0mL fresh blood was collected and mixed. The
tube was then centrifuged in a horizontal rotor (swing-out
head) (Hettich Zentrifugen, 32 R, Germany) for 15 minutes.
Immediately after centrifugation, the buffy coat containing
lymphocytes was gently aspirated with a Pasteur pipette and
transferred into 25 cm2 cell culture flasks containing RPMI-
1640 medium (ATCC, USA) supplemented with L-glutamine
(2Mm), 15% heat inactivated fetal calf serum (FCS) (ATCC,
USA), 100 units/mL penicillin, and 100𝜇g/mL streptomycin
(SigmaAldrich,USA).Theflaskwas incubated at 37∘C in a 5%
CO
2
environment. After reaching 90% confluency, the cells
were counted and plated in triplicate in 96-well microtitre
plate (TPP, Switzerland). The antiproliferative effect of S-
GPNs on the lymphocytes was investigated for 24, 48, and 72
hours by trypan blue exclusion assay.
2.10. Morphological Assessment of Apoptosis. K562 cells (1 ×
105 cells/mL) were seeded on a 25 cm2 culture flask and
treated with IC
50
values of S-GNPs for 24, 48, and 72 hours.
Later, the cells were collected andwashed twice with cold PBS
and stained in dark with 10𝜇L Hoechst 33342 (1mM) and
5 𝜇L PI (100 𝜇g/mL) on glass slides. The cells were visualized
using an Olympus BHZ, RFCAmicroscope (Japan) equipped
with a fluorescent light source with an excitation wavelength
of 330 nm and a barrier filter of 420 nm.
2.11. Annexin V-FITC Assay. Apoptosis was detected with an
annexinV-FITCkit (SigmaAldrich,USA) in accordancewith
the instructions of the manufacturer without any modifica-
tion. Briefly, K562 cells at a concentration of 1 × 106 cells/mL
were exposed to S-GNPs for 6, 12, and 24 hours.The cells were
then collected and centrifuged at 1500 rpm for five minutes
to remove the media.Then, the cell pellets were washed twice
with 1mLPBS and centrifuged. Subsequently, the pellets were
resuspended in 500 𝜇L ice-cold 1x binding buffer, to which
5 𝜇L of annexin V-FITC conjugate and 10 𝜇L of propidium
iodide (PI) were added. The cells were gently vortexed and
incubated for 15minutes in the dark. Flow cytometric analysis
was immediately conducted using laser emitting excitation
light at 488 nm and a BD flow cytometer equipped with an
Argon laser (Cyan ADP, DAKO, Glostrup, Denmark). Lastly,
the analysis was carried out using Summit V4.3 software.
2.12. Cell Cycle Assay. The flow cytometer was used to sup-
port the cytotoxicity of S-GNPs towards K562 cells. Briefly,
cells at a density of 2.5 × 106 cells/mL were cultured with
the S-GNPs and incubated for 12, 24, and 48 hours. The
cells were harvested by centrifugation at 1500 rpm/5 minutes
and washed with 1mL PBS. Subsequently, 600 𝜇L of 80% ice
cold ethanol was added to the cell pellets drop by drop with
continuous vortexing to prevent clumping and aggregation
of cells and then kept at 20∘C for five days. Then 1mL PBS
was added and spun down at 1500 rpm/5 minutes. After
that, the cell pellets were harvested again and washed twice
with 1mL PBS. Finally, collected cells were stained with a
PBS staining buffer that contained 0.1% triton X-100, 10mM
EDTA, 50 𝜇g/mL RNAase A, and 3 𝜇g/mL PI and incubated
in the dark on ice for 20 minutes. Flow cytometric analysis
was conducted using laser emitting excitation light at 488 nm
using a BD FACSCalibur flow cytometer equipped with an
Argon laser (BD, USA). Data analysis was performed using
CellQuest Pro software.
2.13. Caspase Assay. The protease activity of caspases 3 and
9 in K562 cells was performed using a colorimetric assay
kit (Gene script kit, code: L00289, Piscataway, NJ 08854,
USA). About 2 × 106 cells were treated with S-GNPs at IC
50
concentration and incubated for 24 and 48 hours, while the
untreated cells incubated for 24 and 48 hours acted as control.
Then, the cells were centrifuged for five minutes at 1500 rpm
to remove the media, following which the cells were washed
twice with PBS, and centrifuged again at 1500 rpm/5minutes.
The cell pellets were lysed by the addition of 50𝜇L cold
prepared lysis buffer,mixedwell, and incubated on ice for one
hour.The resulting cell lysate was centrifuged for one minute
at 10,000 rpm at 4∘C, and the supernatant was collected. The
protein concentrations in each tube were quantified using the
Bradford method. Then 50𝜇L 2x reaction buffer was added
to 50 𝜇L supernatant containing 200𝜇g protein in each tube.
Subsequently, 5 𝜇L caspase substrate was added, transferred
to a 96-well plate, wrapped, and incubated at 37∘C for four
hours in dark. Finally, the samples were read at 405 nm in
a microplate reader (Universal Microplate reader) (Biotech,
Inc., USA). Data were presented as optical density (OD)
(405 nm; mean SD) and a histogram was plotted.
2.14. Statistical Analysis. The experiments were done in
triplicate and results were expressed as mean ± SD. Statistical
analyses were done using SPSS version 20.0 (SPSS Inc.,
Chicago,USA).Datawere initially evaluated for homogeneity
of variance and normality. Probability values of less than
alpha (𝑃 < 0.05) were considered statistically significant.
3. Results and Discussion
Several natural products, including plants and herbs, have
been successfully used in the efficient and rapid synthesis of
different metal nanoparticles [3]. Such biomedically active
components found in plants and herbal preparations have
the advantage of being supportive in stabilizing nanoparticles
without toxicity. Gold nanoparticles (GNPs) show potential
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Figure 1: The color change of S. muticum aqueous extract at the
beginning (a); 30min (b); and 1 h (c) after synthesis of S-GNPs.
inmany areas of biomedical sciences, including the treatment
of cancer. Recently, natural products have been reported
elsewhere for the green synthesis of metallic nanoparticles
as reducing and stabilizing agents. Seaweed, one of the most
commonly used medicinal extracts, has been acknowledged
to exhibit anticancer activity in vitro and in vivo and in human
clinical trials.
3.1. Synthesis of S-GNPs. In the current study, we synthesized
Sargassum muticum stabilized gold nanoparticles via the
one-step process, without the requirement of a stabilization
or reducing agent. This method allows the production of
gold nanoparticles within one hour (Figure 1). The gold
nanoparticles generated through the seaweed-mediated pro-
cess did not aggregate, suggesting that the cocktail of phyto-
chemicals, including fucoxanthin, serve as excellent coatings
on nanoparticles and thus provide strong protection from
aggregation. The AuCl
4
reduction was visually obvious from
the changes in color from light purple to a ruby red color
indicating the completed formation of S-GNPs, within one
hour.
3.2. Characterization of S-GNPs. Thepresence of S-GNPswas
confirmed by the characteristics of a surface plasmon reso-
nance band of GNPs observed in the UV-Visible spectrum
(Figure 2).Themeasured average zeta potential was−35.8mV
(Figure 3).This low value suggested that the S-GNPs solution
was stable. The size distribution histogram showed mostly
spherical shape GNPs with particle size distribution and
mean diameter of 5.42 ± 1.18 nm by TEM (Figure 4).
The fucoxanthin or polysaccharides, polyphenol, and
other components within the Sargassum muticum not only
result in the efficient reduction of gold salts to nanoparticles,
but, in the same way as a proper capping agent, prevent
them from aggregation. A very important requirement for
nanoparticles biosynthesis for medical applications is aggre-
gation resistance in different pH or in high ionic strength
environments [32]. In the current study the S-GNPs stability
was tested over time and did not show any obvious variation
in particle shape and size even after several months’ storage at
room temperature; in addition, S-GNPs in the pH range of 2–
10 showed no discernible change in the intensity or position
of the absorbance at 520 nm.
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Figure 2: UV-Vis spectra of S-GNPs solution at different time of
reaction.
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Figure 3: Zeta potential of biosynthesized S-GNPs.
Recently, another research group synthesized AgNPs and
AuNPs with calcium alginate by using a photochemical
approach via a UV light source [33]. One polysaccharide that
is widely dispersed in the brown algae cell walls is alginic acid
[34]. In this study calcium alginate gel was used as both a
reducing agent and stabilizer and resulted in nanoparticles
that were spherical in shape and crystalline with a size of
<10 nm.
3.3. Cytotoxicity of S-GNPs. The results of the cytotoxicity
were tested by observing the cellular morphological change,
which showed that S-GNPs had no toxicity to the normal
human blood mononuclear cells using trypan blue exclusion
assay (Figure 5). S-GNPs, however, dose and time depen-
dently inhibited the proliferation of the human leukemia cell
lines.The IC
50
values calculated for S-GNPs were 4.22± 1.12,
5.71 ± 1.4, 6.55 ± 0.9, and 7.29 ± 1.7 𝜇g/mL for K562, HL-
60, Jurkat, and CEM-ss cells, respectively, after treatment
for 72 hours (Figure 6). The IC
50
value calculated for pure
Sargassum muticum methanol extract was 20.0 ± 0.4 𝜇g/mL,
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Figure 4: TEM images ((a)-(b)) and corresponding size distribution graph (c) of biosynthesized S-GNPs.
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Figure 5: Cytotoxic effect of S-GNPs onCEM-ss, Jurkat, HL-60, and
K562 cells assessed by MTT assay. Each point is the mean value of
three replicates.
which is three times higher than the S-GNPs. It is also
important to point out that the vast majority of Gold (I) and
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Figure 6: Cytotoxic effect of S-GNPs on human bloodmononuclear
cells. Values are expressed as mean ± SD of three different experi-
ments. The data has been analyzed using post hoc comparison test-
one way ANOVA, means compared with Tukey’s-𝑏 test.
Gold (III) compounds show varying degrees of cytotoxicity
to a variety of cells [35].
These results clearly demonstrated that the biomedical
active components such as fucoxanthin within seaweed pro-
vide a nontoxic coating on GNPs. The lack of any noticeable
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Table 1: Flow cytometric analysis of K562 cells after being treated with S-GNPs.The cells were stained with FITC-conjugated annexin V and
PI and incubated at 37∘C for 6, 12, and 24 h, respectively.
Cell condition Control Treated/6 h Treated/12 h Treated/24 h
Viable cells 96.5 ± 0.55 89.19 ± 0.65 80.21 ± 0.11 71.5 ± 0.23
Early apoptosis 1.81 ± 0.15 6.55 ± 0.75∗ 9.00 ± 0.33∗ 12.25 ± 0.25∗
Late apoptosis/necrosis 1.69 ± 0.35 4.26 ± 0.05∗∗ 10.79 ± 0.40∗∗ 16.25 ± 0.19∗∗
Values are expressed as mean ± SD of three different experiments. The data has been analyzed using post hoc comparison test-one way ANOVA, means
compared byTukey’s-𝑏 test. (∗): significant (𝑃 < 0.05) increased early apoptotic cells in S-GNPs treated groups compared to untreated controls. (∗∗): significant
(𝑃 < 0.05) increased late apoptotic/necrotic cells in S-GNPs treated groups compared to untreated controls.
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Figure 7: Fluorescentmicrograph ofHoechst 33342 stainedK562 cells that were treated with S-GNPs. (a) Untreated cells showing normal size
and cell structure. (b) Early apoptotic cells after 24 h treatment showing chromatin condensation and membrane blebbing. (c) Blebbing and
cell shrinkage after 48 h treatment. (d)Membrane blebbing, cell shrinkage, and apoptotic body formation after 72 h treatment. CC: chromatin
condensation, BL: blebbing, CS: cell shrinkage, and AB: apoptotic body.
toxicity of S-GNPs provides new opportunities for the safe
delivery and applications in anticancer therapy.
3.4. Morphological Assessment of S-GNPs. Apoptosis was
identified with Hoechst 33342 staining time dependently
in the treated cells. Staining the 24-hour S-GNPs treated
K562 cell exhibited the typical features of apoptosis, such as
chromatin condensation and morphology changes, as well
as cell shrinkage and membrane blebbing. The 48-hour S-
GNPs treated cells showed even smaller nuclei; some had
peripherally condensed or clumped chromatin, whereas oth-
ers showed membrane blebbing. Apoptotic bodies formation
was more prominent at 72 hours after treatment of S-GNPs.
In contrast, the cells in the control group, without treat-
ment, demonstrated normal nuclear and cellularmorphology
(Figure 7). Lan et al. also showed that AuNPs with an average
diameter of 20.5 nm reduced cell viability of nasopharyngeal
carcinoma cell in a concentration-dependant manner by
trypan blue assay, especially at high concentration [36].
3.5. Apoptosis Evaluation. In order to quantify the apoptosis,
an annexin V-FITC/PI staining experiment was performed
to examine the occurrence of phosphatidylserine externaliza-
tion onto the cell surface. The percentage of annexin V-FITC
stained cells, both the early and late apoptotic cells, increased
gradually and significantly (𝑃 < 0.05) in all groups with the
time applied, while the percentage of viable cells subsequently
decreased gradually (Figure 8). At six hours of treatment, an
abundance of cells developed primarily in the early phase of
apoptosis (6.55 ± 0.75%), while increasing incubation time
of 12 and 24 hours, respectively, induced more cell apoptosis
during the late stage (9.00 ± 0.33% and 12.25 ± 0.25%, resp.)
(Table 1).
Similar results in apoptosis enhanced cell death by
(-)-epigallocatechin-3-flat gold nanoparticles (EGCG-PNG)
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Figure 8: Flow cytometric analysis of apoptosis induction by S-GNPs in K562 cells after staining with FITC-conjugated annexin V and PI.
(a) Untreated (control) K562 cells. (b), (c), and (d) Effects of 6, 12, and 24 h S-GNPs treatment, respectively.
were found by other groups in B16F10murinemelanoma cells
with increasing fraction of annexin V positive cells. This, in
turn, improved the anticancer efficacy of (-)-epigallocat-
echin-3-flat gold nanoparticles in murine B16F10 melanoma
cells.
3.6. Cell Cycle Analysis. It demonstrated that the untreated
cells showed normal DNA content and cell cycle distribution.
On the other hand, S-GNPs induced a concomitant and
significant (𝑃 < 0.05) accumulation of K562 cell populations
with an apoptotic peak in the SubG0/G1 phase especially at 48
hours of treatment (6.69±0.56%).Moreover, S-GNPs induced
cell cycle arrest in the G2/M phase with values of 27.14 ±
0.41%, 30.47 ± 0.35%, and 33.83 ± 0.93% after 12, 24, and
48 hours of treatment, respectively (Figure 9 and Table 2).
Huang et al. demonstrated that AuNPs with surfacemod-
ification, using polyethylene glycol (PEG-AuNPs), inhibited
the viability of human chronic myeloid leukemia K562 cells.
These particles caused morphological changes typical of cell
death, and a marked increase in the sub-G1 population in
DNA histogram, indicating apoptosis. In addition, PEG-
AuNPs reduced the mitochondrial transmembrane potential,
a hallmark of the involvement of the intrinsic apoptotic
pathway in K562 cells [37].
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Table 2: Flowcytometric analysis of K562 cells after being treated with S-GNPs. The cells were stained with PI and incubated at 37∘C for 12,
24, and 48 h.
Cell cycle phases Cells %
Control Treated/12 h Treated/24 h Treated/48 h
G0/G1 54.33 ± 0.06 51.36 ± 0.45 50.56 ± 0.52 47.10 ± 0.68
G2/M 22.52 ± 0.76∗ 27.14 ± 0.41∗ 30.47 ± 0.35∗ 33.83 ± 0.93∗
Synthesis 15.26 ± 0.06 18.22 ± 0.33 14.97 ± 0.12 13.11 ± 0.18
Sub-G0/G1 1.49 ± 0.23 3.39 ± 0.28∗∗ 4.73 ± 0.20∗∗ 6.69 ± 0.56∗∗
Values are expressed as mean ± SD of three different experiments. The data has been analyzed using post hoc comparison test-one way ANOVA, means
compared with Tukey’s-𝑏 test. (∗): significant (𝑃 < 0.05) increased cells in G2/M phase in S-GNPs treated groups compared to untreated controls. (∗∗):
significant (𝑃 < 0.05) increased of apoptotic cells in sub-G0/G1 phase in S-GNPs treated groups compared to untreated controls.
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Figure 9: Cell cycle analysis of K562 cells treated with S-GNPs after staining with PI. (a) Untreated (control) K562 cells. (b), (c), and (d)
Effects of 12, 24, and 48 h, respectively, exposure of K562 cells to S-GNPs. G0/G1, G2/M, and S indicate the cell phase, and sub-G0-G1 refers
to the portion of apoptotic cells.
3.7. Caspase Activity. To investigate the involvement of cas-
pases signaling cascade in S-GNPs induced apoptosis, K562
cells were treated for various times and protease enzymatic
activities were determined. S-GNPs significantly (𝑃 < 0.05)
stimulated both caspases 3 and 9 enzyme activities with
more than onefold activity in a time-dependent manner
in the treated K562 cells, compared to untreated control
groups (Figure 10 and Table 3). Similar results of caspase
protease activity were found in other types of nanoparticles,
such as lipid nanoparticles, by Rahman et al. in human
lymphoblastoid leukemia Jurkat cells after treatment with
zerumbone-loaded nanostructured lipid carrier (ZER-NLC).
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Table 3: Caspases spectrophotometric analysis of K562 cells after being treated with S-GNPs for 24 and 48 h, respectively.
Caspase Cells %
Control/24 h Treated/24 h Control/48 h Treated/48 h
Caspase-3 0.055 ± 0.035 0.15 ± 0.03∗ 0.077 ± 0.041 0.20 ± 0.009∗
Caspase-9 0.061 ± 0.071 0.17 ± .005∗ 0.079 ± 0.007 0.22 ± 0.0055∗
Values are expressed as mean ± SD of three different experiments. The data has been analyzed using post hoc comparison test-one way ANOVA, means
compared with Tukey’s-𝑏 test. (∗): significant (𝑃 < 0.05) increase of apoptotic cells in S-GNPs treated groups compared untreated controls.
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Figure 10: Effect of S-GNPs treatment on K562 cell caspases 3 and
9. The values are mean ± SD of three independent experiments.
Significant differences (𝑃 < 0.05) between treated and control
groups for caspases 3 and 9 are found.
Taken together, this is the first report that S-GNPs induced an
antiproliferative effect on human blood cancer cells through
mitochondrial disruption, leading to cell cycle arrest at the
G2/M phase, and subsequently apoptotic cell death.
4. Conclusion
Most chemotherapeutics for the treatment of cancers are
plagued with toxic side-effects, which too often prove fatal.
S-GNPs do not show these side-effects nor do they affect
normal cells adversely. Our results showed that S-GNPs
possess selective cytotoxicity towards human leukemia cells,
which induce apoptosis in a time-dependent manner. The
apoptogenic effect of S-GNPs appears to occur via the mito-
chondrial intrinsic pathway through caspases 3 and 9 activa-
tion.Thus, S-GNPs can be further developed into a safe ther-
apeutic compound, for the treatment of not only leukemias,
but also other cancers.
However, fucoxanthin is considered to be the most active
compound in the S. muticum extract, in which themajority of
anticancer activity may be due to its activity, but the process
of isolating more active ingredient from the extract should
be done in a near future. On the other hand, the acute and
chronic toxicity of S-GNPs is in the process of evaluation to
confirm the safety of this new drug to be further used for
treating of human ailments.
Conflict of Interests
All authors declare no conflict of interests.
Acknowledgments
The authors are grateful to the staff of the Institute of Tropical
Forestry and Forest Products (INTROP) and Institute of
Bioscience (IBS), Universiti Putra Malaysia (UPM), for their
kind help and support of this study.
References
[1] R. Siegel, D.Naishadham, andA. Jemal, “Cancer statistics, 2012,”
CA: A Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29,
2012.
[2] W. Cai, T. Gao, H. Hong, and J. Sun, “Applications of gold nano-
particles in cancer nanotechnology,” Nanotechnology, Science
and Applications, vol. 1, pp. 17–32, 2008.
[3] Y. Park, Y. N. Hong, A. Weyers, Y. S. Kim, and R. J. Linhardt,
“Polysaccharides and phytochemicals: a natural reservoir for
the green synthesis of gold and silver nanoparticles,” IET Nano-
biotechnology, vol. 5, no. 3, pp. 69–78, 2011.
[4] S. Jain, D. G. Hirst, and J. M. O’Sullivan, “Gold nanoparticles as
novel agents for cancer therapy,” British Journal of Radiology,
vol. 85, no. 1010, pp. 101–113, 2012.
[5] S. Sunkar and C. V. Nachiyar, “Synthesis and characterization of
biologically synthesized antibacterial silver nanoparticles using
the endophytic bacterium Bacillus cereus: a novel source in the
Benign synthesis,” Global Journal of Medical Research, vol. 12,
no. 2, pp. 42–50, 2012.
[6] X. Li, H. Xu, Z.-S. Chen, andG.Chen, “Biosynthesis of nanopar-
ticles by microorganisms and their applications,” Journal of
Nanomaterials, vol. 2011, Article ID 270974, 16 pages, 2011.
[7] M. Gericke and A. Pinches, “Microbial production of gold
nanoparticles,” Gold Bulletin, vol. 39, no. 1, pp. 22–28, 2006.
[8] L. Liu, M. Heinrich, S. Myers, and S. A. Dworjanyn, “Towards a
better understanding of medicinal uses of the brown seaweed
Sargassum in traditional Chinese medicine: a phytochemical
and pharmacological review,” Journal of Ethnopharmacology,
vol. 142, no. 3, pp. 591–619, 2012.
10 Journal of Nanomaterials
[9] F. Namvar, P. M. Tahir, R. Mohamad et al., “Biomedical proper-
ties of edible seaweed in cancer therapy and chemoprevention
trials: a review,”Natural Product Communications, vol. 8, no. 12,
pp. 1811–1820, 2013.
[10] F. Namvar, S. Mohamed, S. G. Fard et al., “Polyphenol-rich
seaweed (Eucheuma cottonii) extract suppresses breast tumour
via hormonemodulation and apoptosis induction,” Food Chem-
istry, vol. 130, no. 2, pp. 376–382, 2012.
[11] A. A. El Gamal, “Biological importance of marine algae,” Saudi
Pharmaceutical Journal, vol. 18, no. 1, pp. 1–25, 2010.
[12] F. Namvar, J. Baharara, and A. A. Mahdi, “Antioxidant and anti-
cancer activities of selected persian gulf algae,” Indian Journal of
Clinical Biochemistry, vol. 29, no. 1, pp. 13–20, 2013.
[13] M. N. A. Khan, J. S. Choi, M. C. Lee et al., “Anti-inflammatory
activities of methanol extracts from various seaweed species,”
Journal of Environmental Biology, vol. 29, no. 4, pp. 465–469,
2008.
[14] A. W. Zuercher, R. Fritsche´, B. Corthe´sy, and A. Mercenier,
“Food products and allergy development, prevention and treat-
ment,” Current Opinion in Biotechnology, vol. 17, no. 2, pp. 198–
203, 2006.
[15] G. R. M. Perez, S. M. A. Zavala, G. S. Perez, and G. C. Perez,
“Antidiabetic effect of compounds isolated from plants,” Phy-
tomedicine, vol. 5, no. 1, pp. 55–75, 1998.
[16] T. Nishino, A. Fukuda, T. Nagumo, M. Fujihara, and E. Kaji,
“Inhibition of the generation of thrombin and factor Xa by a
fucoidan from the brown seaweed Ecklonia kurome,”Thrombo-
sis Research, vol. 96, no. 1, pp. 37–49, 1999.
[17] K. Miyashita, “The carotenoid fucoxanthin from brown sea-
weed affects obesity,” Lipid Technology, vol. 21, no. 8-9, pp. 186–
190, 2009.
[18] S. Mohamed, S. N. Hashim, and H. A. Rahman, “Seaweeds: a
sustainable functional food for complementary and alternative
therapy,” Trends in Food Science and Technology, vol. 23, no. 2,
pp. 83–96, 2012.
[19] K. Wada, K. Nakamura, Y. Tamai et al., “Seaweed intake and
blood pressure levels in healthy pre-school Japanese children,”
Nutrition Journal, vol. 10, no. 1, article 83, 2011.
[20] A. Bocanegra, S. Bastida, J. Benedı´, S. Ro´denas, and F. J.
Sa´nchez-Muniz, “Characteristics and nutritional and
cardiovascular-health properties of seaweeds,” Journal of
Medicinal Food, vol. 12, no. 2, pp. 236–258, 2009.
[21] I. A. Brownlee, A. Allen, J. P. Pearson et al., “Alginate as a source
of dietary fiber,” Critical Reviews in Food Science and Nutrition,
vol. 45, no. 6, pp. 497–510, 2005.
[22] I. Brownlee, A. Fairclough, A. Hall, and J. Paxman, Dietary
Seaweed and Human Health, Centre for Food Innovation,
Sheffield Hallam University, Sheffield, UK, 2011.
[23] J. H. Fitton, “Therapies from fucoidan; multifunctional marine
polymers,”Marine Drugs, vol. 9, no. 10, pp. 1731–1760, 2011.
[24] C. Gerhauser, “Cancer chemoprevention and nutri-epigenetics:
state of the art and future challenges,” Topics in Current
Chemistry, vol. 329, pp. 73–132, 2013.
[25] F. Namvar, S. Azizi, M. B. Ahmad et al., “Green synthesis and
characterization of gold nanoparticles using the marine macro-
algae Sargassummuticum,” Research on Chemical Intermediates,
vol. 41, no. 8, pp. 5723–5730, 2015.
[26] R. Zahra, M. Mehrnaz, V. Farzaneh, and S. Kohzad, “Antiox-
idant activity of extract from a brown alga, Sargassum bove-
anum,”African Journal of Biotechnology, vol. 6, no. 24, pp. 2740–
2745, 2007.
[27] P. Matanjun, S. Mohamed, N. M. Mustapha, and K. Muham-
mad, “Nutrient content of tropical edible seaweeds, Eucheuma
cottonii, Caulerpa lentillifera and Sargassum polycystum,” Jour-
nal of Applied Phycology, vol. 21, no. 1, pp. 75–80, 2009.
[28] K. H. Wong and P. C. K. Cheung, “Nutritional evaluation of
some subtropical red and green seaweeds: part I—proximate
composition, amino acid profiles and some physico-chemical
properties,” Food Chemistry, vol. 71, no. 4, pp. 475–482, 2000.
[29] S. L. Holdt and S. Kraan, “Bioactive compounds in seaweed:
functional food applications and legislation,” Journal of Applied
Phycology, vol. 23, no. 3, pp. 543–597, 2011.
[30] J. Ortiz, N. Romero, P. Robert et al., “Dietary fiber, amino acid,
fatty acid and tocopherol contents of the edible seaweeds Ulva
lactuca and Durvillaea antarctica,” Food Chemistry, vol. 99, no.
1, pp. 98–104, 2006.
[31] P. Kumari, M. Kumar, V. Gupta, C. R. K. Reddy, and B. Jha,
“Tropical marine macroalgae as potential sources of nutrition-
ally important PUFAs,” Food Chemistry, vol. 120, no. 3, pp. 749–
757, 2010.
[32] S. Pandey and G. Oza, “Green synthesis of highly stable gold
nanoparticles using Momordica charantia as nano fabricator,”
Archives of Applied Science Research, vol. 4, no. 2, pp. 1135–1141,
2012.
[33] S. Saha, A. Pal, S. Kundu, S. Basu, and T. Pal, “Photochemical
green synthesis of calcium-alginate-stabilized Ag and Au nano-
particles and their catalytic application to 4-nitrophenol reduc-
tion,” Langmuir, vol. 26, no. 4, pp. 2885–2893, 2010.
[34] I.Wijesekara, R. Pangestuti, and S.-K.Kim, “Biological activities
and potential health benefits of sulfated polysaccharides derived
from marine algae,” Carbohydrate Polymers, vol. 84, no. 1, pp.
14–21, 2011.
[35] V. Balzani, “Nanoscience and nanotechnology: the bottom-up
construction of molecular devices and machines,” Pure and
Applied Chemistry, vol. 80, no. 8, pp. 1631–1650, 2008.
[36] M.-Y. Lan, Y.-B. Hsu, C.-H. Hsu, C.-Y. Ho, J.-C. Lin, and S.-W.
Lee, “Induction of apoptosis by high-dose gold nanoparticles in
nasopharyngeal carcinoma cells,” Auris Nasus Larynx, vol. 40,
no. 6, pp. 563–568, 2013.
[37] Y.-C. Huang, Y.-C. Yang, K.-C. Yang et al., “Pegylated gold
nanoparticles induce apoptosis in human chronic myeloid
leukemia cells,”BioMedResearch International, vol. 2014, Article
ID 182353, 9 pages, 2014.
Submit your manuscripts at
http://www.hindawi.com
Scientifica
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Corrosion
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Polymer Science
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Ceramics
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Composites
Journal of
Nanoparticles
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Biomaterials
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Nanoscience
Journal of
Textiles
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Journal of
Nanotechnology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Crystallography
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Coatings
Journal of
Advances in 
Materials Science and Engineering
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Smart Materials 
Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Metallurgy
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Materials
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
N
an
om
at
er
ia
ls
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal ofNanomaterials
